Concourse Financial Group Securities’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 78 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2296 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2293 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2345 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2352 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2319 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2349 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2373 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2404 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2339 |
|